Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IHE vs XPH overlap: 17% of top holdings shared

Bottom line

How much do IHE and XPH overlap?

17% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 18.0% of IHE's assets and 22.9% of XPH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

IHEXPH
Weight overlap (top 25)17%
Shared holdings12
Weight in shared holdings18.0%22.9%
Total positions5967
Expense ratio0.37%0.35%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings IHE and XPH have in common

Holding% of IHE% of XPHOverlap
Merck & Co., Inc.4.55%1.65%1.65%
Elanco Animal Health Incorporated2.81%1.64%1.64%
Corcept Therapeutics Incorporated1.90%1.70%1.70%
Ligand Pharmaceuticals Incorporated1.45%1.94%1.45%
Definium Therapeutics Inc1.39%3.09%1.39%
Liquidia Corp1.28%1.86%1.28%
Indivior Pharmaceuticals, Inc.1.14%1.64%1.14%
Crinetics Pharmaceuticals Inc0.90%1.66%0.90%
Edgewise Therapeutics Inc0.70%1.88%0.70%
Amneal Pharmaceuticals, Inc.0.68%1.72%0.68%
Enliven Therapeutics Inc0.63%2.09%0.63%
Veradermics Inc0.56%2.02%0.56%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IHE

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Bristol-myers Squibb Company — 4.37%
  5. Royalty Pharma Plc — 4.34%
  6. Viatris Inc. — 4.22%
  7. Pfizer Inc. — 3.96%
  8. Zoetis Inc. — 3.73%
  9. Jazz Pharmaceuticals Public Limited Company — 3.45%
  10. Axsome Therapeutics, Inc. — 2.42%
  11. Organon & Co. — 0.81%
  12. Supernus Pharmaceuticals, Inc. — 0.62%
  13. Tarsus Pharmaceuticals Inc — 0.57%

Only in XPH

  1. State Street Global Advisors — 8.58%
  2. MBX Biosciences Inc — 2.72%
  3. Alumis Inc — 2.14%
  4. AtaiBeckley Inc — 2.13%
  5. Trevi Therapeutics Inc — 2.12%
  6. Amylyx Pharmaceuticals Inc — 2.04%
  7. Nuvation Bio Inc — 1.89%
  8. Nektar Therapeutics — 1.88%
  9. Maze Therapeutics Inc — 1.85%
  10. Harrow Inc — 1.81%
  11. EyePoint Inc — 1.77%
  12. Ocular Therapeutix Inc — 1.71%
  13. Pacira BioSciences Inc — 1.65%

Asset mix

Asset typeIHEXPH
Stocks99.9%100.0%
Cash & short-term funds6.3%8.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryIHEXPH
US96.4%98.4%
GB4.3%1.6%
IE3.8%3.0%
CA1.4%3.1%
SG0.2%1.6%
KY0.2%1.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do IHE and XPH overlap?
About 17% by weight. 12 securities appear in both funds' top 25 holdings; they make up 18.0% of IHE's assets and 22.9% of XPH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do IHE and XPH have in common?
The largest shared holdings are Corcept Therapeutics Incorporated, Merck & Co., Inc., Elanco Animal Health Incorporated, Ligand Pharmaceuticals Incorporated, Definium Therapeutics Inc.
Should I own both IHE and XPH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, IHE or XPH?
XPH is broader, with 67 positions versus 59 for IHE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.